跳至主要内容
临床试验/CTRI/2024/04/065699
CTRI/2024/04/065699尚未招募3 期

Impact of Intermittent Fasting and Superfood based Therapeutic dieton Non-alcoholic Fatty Liver Disease Patients: A multicentric Interventional Study - IFSD

IVERSITY GRANTA COMMISSION NFOBC0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Adult age group (18-65 years)
  • - Diagnosed with NAFLD by physicians.
  • - A valid consent

排除标准

  • -NAFLD patients with cirrhosis or hepatocellular carcinoma
  • - Pregnant and lactating lady.
  • - People with other causes of liver disease will be excluded (alcohol, viral, genetic,
  • hepatic viruses A-E, etc.).
  • - Patients who consume more than 20 g of alcohol per day (10 g per day in men)
  • - Those on drugs that can induce fatty liver or insulin sensitization, such as estrogens,
  • amiodarone, methotrexate, tamoxifen, glitazones, and metformin, were also excluded
  • from the study.
  • - Bedridden individuals

研究者

发起方
IVERSITY GRANTA COMMISSION NFOBC

相似试验